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Background: Recent studies have shown interleukin 4 (IL-4) and 5 lipoxygenase (5-LO) to play an important 
role in development of nasal polyposis. Investigation into the genetic factors associated with allergic and non-
allergic nasal polyposis has been examined for more than fifteen years. Despite these efforts, the genetic factors 
underlying the development of nasal polyposis have yet to be clearly understood. The current study examined 
the relationship between C-590T promoter polymorphisms of the IL-4 gene and the presence of nasal polyps. 
Additionally, we examined the levels of 5-LO expression in nasal polyp tissue and its association with the IL-4 
promoter gene polymorphisms. 
Methods: A total of 320 subjects were enrolled in the study, of which 256 were healthy controls and 64 were 
patients with nasal polyps. The Real-Time PCR HRM-based method was used to determine the genotypes of 
IL-4 C-590T. The expression of 5-LO within the 64 samples of nasal polyp tissue was determined by 
immunohistochemical staining to examine the association of 5-LO with the IL-4 C-590T genotype.      
Results: Genetic analysis showed a significant difference in the frequencies of the IL-4 polymorphisms at C-590T in 
patients with nasal polyps as compared with controls (p<0.001). No significant difference was seen in the expression 
of 5-LO among genotypes in patients with nasal polyps (p=0.139). 
Conclusions: The results suggest that the inheritance of TT and CT genotypes at the IL-4 C-590T promoter 
gene is associated with nasal polyps however, there is no association between the expression of 5-LO in nasal 
polyp tissues and IL-4 C-590T genotypes in patients with nasal polyps.  
 




Within the paranasal sinuses and nasal cavity, 
painless benign growths termed nasal polyps 
can develop resulting from the presence of an 
inflammatory reaction of the nose, paranasal sinuses,  
 
and lower airway. Nasal polyposis has been 
associated with several different factors including: 
asthma, rhinitis, recurrent infections, aspirin 
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and immune disorders, pollutants, and genetics (1-
3). Recent studies have shown that type 2 cytokines, 
particularly interleukin(IL)-4, hold a central role in 
the pathology of allergic diseases (4-6). Additionally, 
the T allele of the -590 C/T polymorphism in the 
promoter region of the IL-4 gene is associated with 
increased IL-4 gene promoter activity which has the 
potential role to increase the production of IL-4 
(7,8). Polymorphisms in the promoter region of the 
IL-4 gene have been previously examined, however, 
the results appear to be inconclusive (9,10). The 
etiology of polyp development remains unclear. 
Some studies have reported a positive family history 
of nasal polyposis, while others have shown an 
association with various single nucleotide 
polymorphisms (11-15). Arachidonic acid is the 
precursor of powerful biological mediators that play 
a central role in controlling biological systems. Two 
major enzymatic pathways are capable of 
metabolizing arachidonic acid: the cyclooxygenase 
(COX) and the 5-lipoxygenase (5-LO) pathway 
(16). The 5-LO enzyme serves as a critical regulator 
in the synthesis of inflammatory mediators and 
leukotrienes (LTs) (17). Previous studies have 
shown cysteinyl leukotrienes (CysLts) to be 
upregulated by 5-LO in nasal polyp tissues (18, 19). 
Interleukin(IL)-4 and -13 also have been shown to 
have regulatory effects on the expression of 
cysteinyl leukotriene 1 receptor (CysLT1R). 
CysLT1R is expressed on monocytes and 
macrophages, modulating their cellular 
responsiveness to leukotriene D4 (LTD4) and is 
involved in the pathogenesis of allergic diseases 
(20). The current study evaluated the association 
between IL-4 -590 C>T gene polymorphisms and 
the susceptibility to nasal polyposis. Additionally, 
we investigated the expression of 5-LO within nasal 
polyp tissues and the association of the presence of 
this enzyme with IL-4 -590 C>T gene 
polymorphisms. 
 
Materials and methods 
Ethics Statement 
All participants were selected from Kerman, a city 
in southeastern Iran. All individuals provided written 
informed consent prior to enrollment in the study. 
The research was performed from 2014 to 2015, and 
was approved by the Ethical Committee of the 
Kerman University of Medical Sciences. The 
approval number is K/93/106. 
Selection of patients and controls 
A total of 320 subjects were including in the study. 
Of the total participants, 256 were healthy controls 
from the Kerman Blood Transfusion Center and 64 
were patients with nasal polyps. Patients with nasal 
polyps were recruited from the Department of 
Otorhinolaryngology at Kerman University of 
Medical Sciences in Kerman, Iran. The diagnosis of 
nasal polyps was made based on clinical history, 
paranasal sinus computed tomography scans, and 
confirmed through histopathological examination. 
In order to avoid including patients with allergic 
rhinitis, patients with a previous history of itchy 
eyes, nose, or throat that was accompanied by a 
runny nose and tearing during a specific season or 
following exposure to specific substances or in 
specific places were excluded. Prick tests were not 
considered in the exclusion process for patients with 
allergic rhinitis. Patients with a history of 
antrochoanal polyps, polyps associated with cystic 
fibrosis, or fungal sinusitis were excluded from the 
study. Those suffering from primary ciliary 
dyskinesia, chronic periodontal disease, cancer, 
inflammation, rheumatoid arthritis, inflammatory 
bowel disease, or any other inflammatory diseases 
were also excluded. Furthermore, patients were 
excluded if they had been taking any steroids 
(systemic or topical), anti-histamines, non-steroidal 
anti-inflammatory drugs (NSAIDs), or macrolide 
antibiotics the month prior to beginning the study. 
Nasal polyp tissues were removed from the middle 
meatus at the beginning of the surgical procedure via 
ppolypectomy by endoscopic approach. The 
expression of 5-LO in the nasal polyps of patients 
was determined using immunohistochemical 
staining. Venous blood samples were collected from 
patients with nasal polyps and from healthy controls 
to determine the genotype of IL-4 -590 C>T. The 
healthy controls, selected from the Kerman Blood 
Transfusion Center, had no history of systemic or 
organ specific autoimmune diseases, allergy, 
infectious diseases, cancer, or gastrointestinal 
diseases. who were taking immunosuppressive 
drugs or corticosteroids were excluded from the 
study. Demographic data showed the frequency of 
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females (number= 120). The male and female 
frequencies for patients were 46.9% and 53.1%, 
respectively. The mean age for patients and controls 
was 38.2 ± 13.26 and 36.95 ± 11.91 years, 
respectively. The controls and the patients with nasal 
polyps were age- and sex-matched. 
Real-Time PCR high-resolution-melting (HRM) 
analysis for IL-4 -590 C>T genotyping 
Genomic DNA was extracted from whole blood 
using the QiaAmp DNA Mini Kit (Qiagen, 
Valencia, Ca, USA). The forward and reverse 
primers for IL-4 -590 C>T gene polymorphisms 
were 5’-ACTAGGCCTCACCTGATACG-3’ and 
5’-GTTGTAATGCAGTCCTCCTG-3’, 
respectively. The Real-Time PCR HRM-based 
method was used to detect the different genotypes. 
The assay was performed using SYBR Green qPCR 
master mix (Thermoscientific, K0221) under the 
following conditions: holding at 50 °C for 2 
minutes, initial denaturation at 95 °C for 15 minutes 
followed by 40 cycles of denaturation at 95 °C for 
10 seconds and annealed at 60 °C for 40 seconds. 
HRM ramps were generated by acquiring 
fluorescence data at a temperature ramp from 65 °C 
to 88 °C. The mean temperatures for genotypes of 
CC, CT, and TT were 84 °C, 81 °C, and 82 °C, 
respectively. The genotype was assigned according 
to the shape of the HRM curve as determined by 
Rotor-Gene software and visual inspection.  
 
Immunohistochemical Staining 
Biopsies from nasal polyps were fixed with 10% 
formalin in phosphate-buffered saline (PBS) 
solution for 24 hours. The tissues were dehydrated 
and embedded in paraffin through routine 
processing. After deparaffinization and rehydration 
with xylene and alcohol, the sections were 
microwaved in 10 mM citrate buffer (pH 6.0) for 10 
minutes and then washed with 3% H2O2 in Tris-
buffered-saline (TBS) for 10 minutes. Another wash 
with TBS was performed for 5 minutes, followed by 
a blocking step for 30 minutes using Blocking 
Solution (DAKO, Hamburg, Germany). Sections 
were incubated with rabbit anti-5-LO monoclonal 
antibody (Abcam, Cambridge, United Kingdom) 
diluted in a 1:250 ratio in Antibody Diluent 
(DAKO, Hamburg, Germany) overnight at 4 °C and 
then washed three times with TBS. In the next step, 
goat Anti-Rabbit IgG conjugated to horseradish 
peroxidase (Abcam, Cambridge, United Kingdom) 
was used as the secondary antibody to enable for the 
detection of the primary antibodies. The sections 
were then washed and incubated with 3,3’-
diaminobenzidine (DAB, Sigma Fast DAB tablet, 
Sigma Chemical Co, St Louis, MO). Finally, the 
sections were washed with TBS and then 
counterstained with hematoxylin. 
Immunohistochemical staining for 5-LO was 
evaluated by the pathologist. Expressions of 5-LO 
were assessed semi-quantitatively as follows: 0 = 
none, 1= 25%, 2 = 25-50%, and 3 = 50%. 
Statistical analysis 
The genotype and allotype frequency deviations 
from the Hardy-Weinberg equilibrium were 
analysed for all individuals. Statistical analyses 
including, logistic regression, two-independent t-test, 
Chi-square, and ANOVA were all performed using 
SPSS software version 17.0. P values less than 0.05 
were considered statistically significant.  
 
Results 
Positive association between IL-4 C-590T 
polymorphism and the development of nasal polyps 
The genotype and allelotype frequencies of the 
IL-4 -590 C>T gene polymorphism for all 
individuals are summarized in Table 1. Analysis 
of the IL-4 -590 C>T gene polymorphism 
showed a significant difference in the 
frequencies of -590 C>T between patients and 
controls (p<0.001). Statistical analysis 
demonstrated that the presence of the T allele at 
position -590 of the IL-4 gene was associated 
with an increased susceptibility of nasal polyp 
development (p<0.0001). The frequencies of 
the CT and TT genotypes were significantly 
higher in patients with nasal polyps than in 
healthy controls (p<0.0001). Conversely, the 
frequency of the CC genotype was significantly 
higher in healthy controls as compared with 
patients with nasal polyps (p=0.003). Statistical 
analysis comparing the genotypes TT and CC, 
CT and CC, CT and TT, among patients and 
controls showed significant p values for all 
conditions (TT versus CC, p <0.0001; CT 
versus CC, p<0.0001; and CT versus TT, p< 
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agreement with Hardy-Weinberg equilibrium in both patient and control groups. 
 
Table 1. Genotype and allele frequencies of IL-4 gene polymorphism at C-590T gene in patients with nasal polyps and controls. 
Control Nasal polyp 
Alleles p 
Control Nasal polyp 
Genotyping IL-4 
N % N % 
N % N % 
483 94.33 60 46.1 C 
<0.00
01 
229 89.5 11 17.2 CC -590 
5.66 29 70 53.8 T  25 9.8 37 57.8 CT  
      2 0.8 16 25 TT C>T 
 
Immunohistochemical analysis of 5-LO in nasal 
polyp tissues  
Immunohistochemical studies revealed that the 
expression rates of 5-LO to be classified as mild, 
moderate, and severe in the submucosa of nasal 
polyps and in the surface of epithelial cells (Fig. 1). 
Expression rates of 5-LO in nasal polyps were 
observed to be weak (46.9%), moderate (26.6%), and 
severe (18.8%). A proportion of the nasal polyp 
tissue, 7.8%, showed no expression of 5-LO. No 
significant differences were found in 5-LO expression 
among the different genotypes of the IL-4 gene. 
 
 
Fig. 1. Expression of 5-lipoxigenase in nasal polyps; A: Negative; B: Mild; C: Moderate, D: Severe. (Horseradish-Peroxidase-EnVision 
method stain; original magnification 400.) 
 
Discussion 
In our study, a significant association was found 
between the occurrence of nasal polyposis and IL-4 -
590 C>T gene polymorphisms. Statistical analysis 
showed that the presence of the T allele at position -
590 of the IL-4 gene is associated with increased 
susceptibility to nasal polyps (p<0.0001). Several 
studies have reported a significant association 
 
between the IL-4 -590 C>T gene polymorphism and 
allergic diseases. In a study by de Guia and Ramos 
(21), it was demonstrated that the -590C>T IL-4 
polymorphism is a potential risk factor for atopic 
allergy. Additionally, a significant association 
between IL-4 -590 C>T and asthma has been 
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backgrounds (22-27). The association between the 
IL-4 -590 C>T gene polymorphism and chronic 
rhino sinusitis were corroborated in a study 
examining the Korean population (28). A separate 
study examining an Iranian population found an 
association between IL-4 -590 C>T gene 
polymorphisms and allergic rhinitis (9). Another 
study of a Korean population showed that the T allele 
at IL-4 -590 was associated with protection against 
non-asthmatic and asthmatic nasal polyposis. These 
results are in disagreement with our findings in which 
the opposite association was found. Interestingly, the 
most common genotype of IL-4 -590 C>T in the 
control Korean population was TT, which was 
different from other races (10). A recent study from 
Ahvaz in southeastern Iran reported a lack of 
association between IL-4 -590 C>T and nasal 
polyposis (29). Discrepancies between these findings 
and our results may be attributed to the differences in 
sample size and exclusion criteria. Moreover, the 
study from Ahvaz included participants from all 
racial groups, whereas our current study selected 
participants exclusively from the city of Kerman. The 
residents in the city of Ahvaz are a mixture of Arab 
and Persian races, and thus may account for the 
differences in our findings.  
5-lipoxygenase (5-LO) has a key role in the 
biosynthesis of LTs from arachidonic acid. A 
previous study showed insignificant increases in 
5-LO expression within the nasal polyp tissues of 
patients when compared with control tissue 
samples (30). Park et al. (31) showed the 5-LO 
expression in non-allergic patients with nasal 
polyps to be significantly increased in individuals 
with the genotype CC, in comparison to those 
with the CT or TT genotype at IL-4 -590. 
Conversely, the results of the present study 
showed a lack of association between the 
expression of 5-LO and all examined IL-4 -590 
gene polymorphism genotypes in patients with 
nasal polyps. The differences in race may have 
contributed to this discrepancy. Moreover, a 
limitation to the current study was a lack of data 
regarding prick tests in patients with nasal polyps. 
This might be another reason for the 
dissimilarities among results.  
In summary, the current study identified a 
relationship between IL-4 -590 C>T 
polymorphisms and nasal polyposis. No 
association was detected between IL-4 -590 C>T 
polymorphism and 5-LO expression levels in 
nasal polyps. However, for a better conclusion 
regarding the role of 5-LO in development of 
nasal polyps, we suggest to increase the sample 
size for future studies.  
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